Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial
CONCLUSIONS: Encouraging safety and preliminary efficacy were observed. Randomized phase II trials are currently ongoing.PMID:37378632 | DOI:10.1158/1078-0432.CCR-23-0416
Source: Cell Research - Category: Cytology Authors: Espen B Ellingsen Steven O'Day Artur Mezheyeuski Agnieszka Gromadka Trevor Clancy Timothy S Kristedja Mohammed Milhem Yousef Zakharia Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cytology | Melanoma | Skin Cancer | Vaccines